Site icon Evolve Business Intelligence

High-Throughput Screening Market Analysis and Forecast 2020-2028

Life Science

The global High-Throughput Screening market size is expected to reach $39.45 Billion by 2028 growing at the CAGR of 11.50% from 2021 to 2028. High-throughput screening (HTS) is a technique for scientific experimentation especially used for drug discovery. Using robotics technology, data processing software, liquid handling devices, and sensitive detectors, high-throughput screening allows the researcher to speedily conduct millions of chemicals, genetic, or pharmacological tests. By this process, the researcher can quickly identify active compounds, antibodies, or genes which modulate an actual biomolecular pathway.  The outcomes of the experiments help for developing drug design and for understanding the noninteraction or role of a particular location.

Parameters Indicators
Market Size (2020) $39.45 Billion
CAGR (2021 to 2028) 11.50%
Market Classificationt Product & Service, Technology, Application, End User
Key Companies Profiled Thermo Fisher Scientific, Agilent Technologies, Inc., Danaher, PerkinElmer, Inc, Tecan Group Ltd., Axxam S.p. A, Bio-Rad Laboratories Inc, Merck Group KGaA, Hamilton Company, and Corning Incorporated
Key Countries/Regions Analyzed US, Canada, Mexico, UK, Germany, France, Italy, Rest of Europe, China, India, Japan, South Korea, Rest of Asia Pacific, Middle East & Africa, and South America
Base Year 2020
Estimated Year 2021
Forecast Years 2022 to 2028

Driving Factors

The factors driving the growth of the global High-Throughput Screening Market include increasing demand for drug discovery, growing use of HTS in academia for biomedical research, rise in the advancement of technology, increase demand for quick data processing, and increase in automation in High-Throughput Screening. This factor is anticipated for the market growth of the market.

  • Increase demand for drug discovery

High-Throughput Screening is used for drug design and drug development. Using High-Throughput Screening, numerous life-threatening diseases drugs can be developed, which increase the High-Throughput Screening market growth.  The high-Throughput Screening process helps to conduct a number of the test quickly, which saves the time of researcher for the drug design and drug development. Moreover, a high-throughput screening technique is beneficial to decrease the cost of drug development. This factor drives the High-Throughput Screening Market.

Restraining factors

The factors restraining the growth of the global High-Throughput Screening Market include high capital investments and a lack of skilled professionals. This factor is expected to restrain the market growth of the market.

Key Insight in the report:

The Global High-Throughput Screening Market report covers Executive Summary, Market Dynamics, Trend Analysis, Market Size and Forecast, Competitive Intelligence, Market Positioning, Product Benchmarking, and Opportunity Analysis.

The report covers extensive competitive intelligence which includes the following data points:

  • Business Overview
  • Business Model
  • Financial Data
  • Financial – Existing
  • Financial – Funding
  • Product Segment Analysis and specification
  • Recent Development and Company Strategy Analysis
  • SWOT Analysis

High-Throughput Screening Market Segmentation

High-Throughput Screening Market

High-Throughput Screening Market

The report covers market sizing and forecasting at the country level as well as at the segment level. High-Throughput Screening Market is analyzed across the below-mentioned different segments:

By Product & Service

  • Reagents & Assay Kits
  • Instruments
  • Consumables & Accessories
  • Software
  • Services

By Technology

  • Cell-based Assays
  • 2D Cell Culture
  • Perfusion Cell Culture
  • Lab-on-a-chip (LOC)
  • Ultrahigh-throughput Screening
  • Bioinformatics
  • Label-free Technology
  • 3D Cell Culture

By Application

  • Target Identification & Validation
  • Primary and Secondary Screening
  • Toxicology Assessment
  • Others

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Government Institutes
  • Contract Research Organizations
  • Others

Regional analysis

Asia Pacific region dominates the high-throughput screening market. It is projected to grow at the highest CAGR during the forecast period, mainly due to factors such as an increase in a public-private partnership, increase in spending for R&D, and rise in government funding.

The High-Throughput Screening Market is analyzed across the below mentioned region.

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Rest of Asia Pacific
  • Rest of the World

High-Throughput Screening Market Ecosystem Players:

Some of the key ecosystem players in of High-Throughput Screening Market include:

  • Thermo Fisher Scientific
  • Agilent Technologies, Inc.
  • Danaher
  • PerkinElmer, Inc
  • Tecan Group Ltd.
  • Axxam S.p. A
  • Bio-Rad Laboratories Inc
  • Merck Group KGaA
  • Hamilton Company
  • Corning Incorporated

REPORT CONTENT BRIEF:

  • High-Throughput Screening Market historical market size for the year 2020, and forecast from 2021 to 2028
  • High-level analysis of the current and future High-Throughput Screening Market trends and opportunities
  • Detailed analysis on current market drivers, restraining factors, and opportunities in the future
  • High-Throughput Screening Market  historical market size for the year 2020, and forecast from 2021 to 2028
  • Vendor market share analysis at each product level
  • High Throughput screening market share with a detailed insight into its product segment, financial strength, and strategies adopted.
  • Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding taken and investment done, among others.
Exit mobile version